Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Sales (2017 - 2025)

Historic Return on Sales for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.14%.

  • Organogenesis Holdings' Return on Sales rose 400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.02% for FY2024, which is 300.0% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Return on Sales of 0.14% as of Q3 2025, which was up 400.0% from 0.09% recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Return on Sales peaked at 0.4% during Q4 2021, and registered a low of 0.22% during Q1 2025.
  • For the 5-year period, Organogenesis Holdings' Return on Sales averaged around 0.04%, with its median value being 0.03% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 3600bps in 2021, then crashed by -3300bps in 2022.
  • Organogenesis Holdings' Return on Sales (Quarter) stood at 0.4% in 2021, then tumbled by -84bps to 0.06% in 2022, then crashed by -109bps to 0.01% in 2023, then crashed by -322bps to 0.02% in 2024, then soared by 694bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q3 2025, 0.09% for Q2 2025, and 0.22% during Q1 2025.